Platelet-activating factor (PAF) is the effector of IFNγ-stimulated invasiveness and motility in a B16 melanoma line

This publication has 31 references indexed in Scilit:

• Platelet-Activating Factor Regulates Cadherin-Catenin Adhesion System Expression and β-Catenin Phosphorylation during Kaposi's Sarcoma Cell Motility
  The American Journal of Pathology, 2005
• Platelet‐activating factor (PAF) induces activation of matrix metalloproteinase 2 activity and vascular endothelial cell invasion and migration
  The FASEB Journal, 2004
• TGF-?-induced invasiveness of pancreatic cancer cells is mediated by matrix metalloproteinase-2 and the urokinase plasminogen activator system
  International Journal of Cancer, 2001
• PAF Produced by Human Breast Cancer Cells Promotes Migration and Proliferation of Tumor Cells and Neo-Angiogenesis
  The American Journal of Pathology, 2000
• Effects of tumor necrosis factor-α and interferon-γ on expressions of matrix metalloproteinase-2 and -9 in human bladder cancer cells
  Cancer Letters, 2000
• Motility Induced by Human Immunodeficiency Virus-1 Tat on Kaposi's Sarcoma Cells Requires Platelet-Activating Factor Synthesis
  The American Journal of Pathology, 1999
• Heterogeneity for integrin expression and cytokine-mediated VLA modulation can influence the adhesion of human melanoma cells to extracellular matrix proteins
  International Journal of Cancer, 1991
• Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages [published erratum appears in J Cell Biol 1988 Sep;107(3):following 1260]
  The Journal of cell biology, 1988
• Tumor necrosis factor/cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesize and release platelet-activating factor.
  The Journal of Experimental Medicine, 1987
• The role of platelet-activating factor in platelet aggregation
  Nature, 1979